Titre :
  • Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1-98.
Auteur : Coates, Alan ; Keshaviah, A ; Thürlimann, Beat ; Mouridsen, Henning ; Mauriac, Louis ; Forbes, John F ; Paridaens, Robert ; Castiglione-Gertsch, Monica ; Gelber, Richard ; Colleoni, Marco Angelo ; Lang, Istvan ; Del Mastro, Lucia ; Smith, Ian ; Chirgwin, Jacquie ; Nogaret, Jean-Marie ; Pienkowski, Tadeusz ; Wardley, Andrew ; Jakobsen, Erik H. ; Price, K ; Goldhirsch, Aron
Informations sur la publication : Journal of clinical oncology, 25, 5, (page 486-492)
Statut de publication : Publié, 2007-02
Sujet CREF : Cancérologie
Mots-clés MeSH : Adult
Aged
Aged, 80 and over
Antineoplastic Agents, Hormonal -- adverse effects -- therapeutic use
Aromatase Inhibitors -- adverse effects -- therapeutic use
Breast Neoplasms -- chemistry -- drug therapy -- pathology
Chemotherapy, Adjuvant
Disease-Free Survival
Double-Blind Method
Estrogen Antagonists -- adverse effects -- therapeutic use
Female
Follow-Up Studies
Humans
Kaplan-Meier Estimate
Middle Aged
Neoplasms, Hormone-Dependent -- chemistry -- drug therapy -- pathology
Nitriles -- adverse effects -- therapeutic use
Postmenopause
Proportional Hazards Models
Receptors, Estrogen -- analysis
Receptors, Progesterone -- analysis
Tamoxifen -- adverse effects -- therapeutic use
Time Factors
Treatment Outcome
Triazoles -- adverse effects -- therapeutic use
Note : Journal Article
Multicenter Study
Randomized Controlled Trial
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langue :
  • Anglais
Identificateurs : urn:issn:0732-183X 
info:doi/10.1200/JCO.2006.08.8617
info:pii/JCO.2006.08.8617
info:pmid/17200148